- STAT+: Longevity, wellness physicians named to panel advising FDA on peptidesThe panel will soon consider whether to relax restrictions on certain peptides.STAT · 27d ago↗ source
- Theravance, after clinical setbacks, agrees to $929M buyout<figure><div><img src="https://imgproxy.divecdn.com/adiJN9GDP_sdBKAPLoO1u858OLmoo_2c7bk4eved-BY/g:nowe:919:1/c:1869:1055/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlc…BioPharma Dive · 27d ago↗ source
- 10 clinical trials to watch in the second half of 2026<p>The biotechnology sector’s upswing accelerated in the first half. Positive results from anticipated trials in lung cancer, Alzheimer’s and multiple autoimmune conditions could add to…BioPharma Dive · 27d ago